| RS1131691715 |
EHMT1
|
Health Risk |
Pathogenic |
— |
| RS1131691716 |
LINS1
|
Health Risk |
Pathogenic |
— |
| RS1131691718 |
HCFC1
|
Health Risk |
Likely pathogenic |
— |
| RS1131691721 |
PUF60
|
Health Risk |
Pathogenic |
— |
| RS1131691724 |
FREM1
|
Health Risk |
Pathogenic |
— |
| RS1131691727 |
SHANK3
|
Health Risk |
Pathogenic |
— |
| RS1131691728 |
ACTA1
|
Health Risk |
Pathogenic |
— |
| RS1131691730 |
FBN1
|
Health Risk |
Pathogenic |
— |
| RS1131691731 |
PHEX
|
Health Risk |
Pathogenic |
Familial X-linked hypophosphatemic vitamin D refractory rickets, Familial X-linked hypophosphatemic vitamin D refractory rickets |
| RS1131691732 |
CDC73
|
Health Risk |
Pathogenic |
Parathyroid carcinoma, Parathyroid carcinoma |
| RS1131691733 |
CHD7
|
Health Risk |
Pathogenic |
— |
| RS1131691734 |
KCNQ2
|
Health Risk |
Pathogenic |
— |
| RS1131691735 |
TCF4
|
Health Risk |
Pathogenic/Likely pathogenic |
Pitt-Hopkins syndrome, Inborn genetic diseases |
| RS1131691736 |
CTNNB1
|
Health Risk |
Pathogenic |
— |
| RS1131691737 |
TBC1D24
|
Health Risk |
Pathogenic |
— |
| RS1131691738 |
COL4A3
|
Health Risk |
Pathogenic/Likely pathogenic |
Alport syndrome, Autosomal dominant Alport syndrome |
| RS1131691740 |
RARB
|
Health Risk |
Pathogenic |
— |
| RS1131691741 |
ATP7B
|
Health Risk |
Conflicting classifications of pathogenicity |
Wilson disease, Inborn genetic diseases |
| RS1131691742 |
STXBP1
|
Health Risk |
Likely pathogenic |
— |
| RS1131691743 |
ABCD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Adrenoleukodystrophy, Inborn genetic diseases |
| RS1131691744 |
TGFB2
|
Health Risk |
Likely pathogenic |
— |
| RS1131691752 |
KCNB1
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 26 |
| RS1131691753 |
COL17A1
|
Health Risk |
Pathogenic |
— |
| RS1131691754 |
NSD1
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Sotos syndrome |
| RS1131691755 |
SMAD2
|
Health Risk |
Pathogenic |
— |
| RS1131691756 |
ZEB2
|
Health Risk |
Pathogenic |
— |
| RS1131691757 |
HYCC1
|
Health Risk |
Likely pathogenic |
Hypomyelination and Congenital Cataract, Hypomyelination and Congenital Cataract |
| RS1131691758 |
PTCH1
|
Health Risk |
Pathogenic |
— |
| RS1131691759 |
ACO2
|
Health Risk |
Pathogenic |
— |
| RS1131691760 |
DNMT3A
|
Health Risk |
Likely pathogenic |
— |
| RS1131691761 |
AR
|
Health Risk |
Pathogenic |
— |
| RS1131691762 |
KCNE1
|
Health Risk |
Pathogenic |
Long QT syndrome, Cardiovascular phenotype |
| RS1131691763 |
ITGB2
|
Health Risk |
Pathogenic/Likely pathogenic |
Leukocyte adhesion deficiency 1, Leukocyte adhesion deficiency 1 |
| RS1131691764 |
MED13L
|
Health Risk |
Pathogenic |
Cardiac anomalies - developmental delay - facial dysmorphism syndrome, Cardiac anomalies - developmental delay - facial dysmorphism syndrome |
| RS1131691766 |
FBN1
|
Health Risk |
Pathogenic |
Familial thoracic aortic aneurysm and aortic dissection, Familial thoracic aortic aneurysm and aortic dissection |
| RS1131691767 |
CNTNAP1
|
Health Risk |
Pathogenic |
— |
| RS1131691768 |
KMT2D
|
Health Risk |
Pathogenic |
— |
| RS1131691769 |
DDX3X
|
Health Risk |
Likely pathogenic |
Intellectual disability, X-linked 102 |
| RS1131691770 |
ADNP
|
Health Risk |
Pathogenic |
— |
| RS1131691771 |
PHIP
|
Health Risk |
Likely pathogenic |
PHIP-related behavioral problems-intellectual disability-obesity-dysmorphic features syndrome, PHIP-related behavioral problems-intellectual disability-obesity-dysmorphic features syndrome |
| RS1131691772 |
FBN1
|
Health Risk |
Likely pathogenic |
— |
| RS1131691773 |
SCN1A
|
Health Risk |
Likely pathogenic |
Early-infantile DEE, SCN1A-related disorder |
| RS1131691774 |
SCN1A
|
Health Risk |
Pathogenic/Likely pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS1131691775 |
SCN1A
|
Health Risk |
Likely pathogenic |
Early-infantile DEE, Migraine |
| RS1131691776 |
SCN9A
|
Health Risk |
Likely pathogenic |
Paroxysmal extreme pain disorder, Paroxysmal extreme pain disorder |
| RS1131691777 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS1131691778 |
WFS1
|
Health Risk |
Likely pathogenic |
Autosomal dominant nonsyndromic hearing loss 6, Autosomal dominant nonsyndromic hearing loss 6 |
| RS1131691782 |
MFN2
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease type 2, Charcot-Marie-Tooth disease type 2 |
| RS1131691783 |
ERCC8
|
Health Risk |
Pathogenic |
Cockayne syndrome type 1, Cockayne syndrome type 1 |
| RS1131691787 |
NEB
|
Health Risk |
Likely pathogenic |
— |
| RS1131691789 |
LAMA1
|
Health Risk |
Pathogenic |
— |
| RS1131691791 |
AGPAT2
|
Health Risk |
Pathogenic/Likely pathogenic |
Congenital generalized lipodystrophy type 1, Congenital generalized lipodystrophy type 1 |
| RS1131691792 |
PDHA1
|
Health Risk |
Pathogenic |
Pyruvate dehydrogenase E1-alpha deficiency, Inborn genetic diseases |
| RS1131691793 |
SCN1A
|
Health Risk |
Pathogenic |
— |
| RS1131691794 |
TSC2
|
Health Risk |
Pathogenic |
Tuberous sclerosis 2, Tuberous sclerosis 2 |
| RS1131691795 |
COL4A5
|
Health Risk |
Pathogenic/Likely pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS1131691799 |
KMT2A
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Wiedemann-Steiner syndrome |
| RS1131691801 |
UBE3A
|
Health Risk |
Pathogenic |
— |
| RS1131691803 |
FBN1
|
Health Risk |
Pathogenic |
Marfan syndrome, Familial thoracic aortic aneurysm and aortic dissection |
| RS1131691804 |
FBN1
|
Health Risk |
Pathogenic/Likely pathogenic |
Metaphyseal chondrodysplasia, Relative macrocephaly |
| RS1131691805 |
FBN1
|
Health Risk |
Likely pathogenic |
— |
| RS1131691806 |
FBN1
|
Health Risk |
Pathogenic |
Marfan syndrome, Marfan syndrome |
| RS1131691807 |
PYGM
|
Health Risk |
Conflicting classifications of pathogenicity |
Glycogen storage disease, type V |
| RS1131691808 |
ACADVL
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Very long chain acyl-CoA dehydrogenase deficiency |
| RS1131691809 |
ARSL
|
Health Risk |
Pathogenic |
— |
| RS1131691810 |
SPTA1
|
Health Risk |
Likely pathogenic |
— |
| RS1131691811 |
TTN
|
Health Risk |
Pathogenic/Likely pathogenic |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS1131691812 |
PHEX
|
Health Risk |
Pathogenic |
— |
| RS1131691813 |
ATP1A3
|
Health Risk |
Conflicting classifications of pathogenicity |
Dystonia 12, Dystonia 12 |
| RS1131691815 |
SPINK5
|
Health Risk |
Pathogenic |
— |
| RS1131691816 |
SHANK3
|
Health Risk |
Pathogenic |
— |
| RS1131691817 |
RAI1
|
Health Risk |
Pathogenic |
— |
| RS1131691818 |
MED13L
|
Health Risk |
Likely pathogenic |
MED13L-related disorder, Cardiac anomalies - developmental delay - facial dysmorphism syndrome |
| RS1131691820 |
COL5A1
|
Health Risk |
Pathogenic |
Ehlers-Danlos syndrome, classic type |
| RS1131691822 |
COL2A1
|
Health Risk |
Pathogenic |
Stickler syndrome type 1, COL2A1-related disorder |
| RS1131691823 |
CPAP
|
Health Risk |
Pathogenic |
Seckel syndrome 4, Seckel syndrome 4 |
| RS1131691826 |
NR2F1
|
Health Risk |
Pathogenic/Likely pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1131691828 |
CYBB
|
Health Risk |
Pathogenic |
Chronic granulomatous disease, Granulomatous disease |
| RS1131691830 |
SCN8A
|
Health Risk |
Pathogenic/Likely pathogenic |
Seizures, benign familial infantile |
| RS1131691831 |
PTEN
|
Health Risk |
Pathogenic/Likely pathogenic |
PTEN hamartoma tumor syndrome, PTEN hamartoma tumor syndrome |
| RS1131691832 |
OPA1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1131691833 |
MYO7A
|
Health Risk |
Likely pathogenic |
— |
| RS1131691834 |
COL4A1
|
Health Risk |
Pathogenic |
— |
| RS1131691835 |
COMP
|
Health Risk |
Likely pathogenic |
Pseudoachondroplastic spondyloepiphyseal dysplasia syndrome, Pseudoachondroplastic spondyloepiphyseal dysplasia syndrome |
| RS1131691836 |
CYBB
|
Health Risk |
Likely pathogenic |
— |
| RS1131691837 |
GALT
|
Health Risk |
Conflicting classifications of pathogenicity |
Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase, Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase |
| RS1131691838 |
SPAST
|
Health Risk |
Likely pathogenic |
— |
| RS1131691839 |
MYH6
|
Health Risk |
Likely pathogenic |
MYH6-related disorder, MYH6-related disorder |
| RS1131691841 |
PHEX
|
Health Risk |
Pathogenic |
Familial X-linked hypophosphatemic vitamin D refractory rickets, Thyroid cancer |
| RS1131691842 |
SBDS
|
Health Risk |
Likely pathogenic |
Aplastic anemia, Aplastic anemia |
| RS1131691844 |
NF1
|
Health Risk |
Likely pathogenic |
— |
| RS1131691845 |
CHAMP1
|
Health Risk |
Pathogenic |
— |
| RS1131691852 |
MPZ
|
Health Risk |
Pathogenic/Likely pathogenic |
Charcot-Marie-Tooth disease, type I |
| RS1131691853 |
HERC1
|
Health Risk |
Likely pathogenic |
— |
| RS1131691861 |
RET
|
Health Risk |
Likely pathogenic |
— |
| RS1131691862 |
LZTR1
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary cancer-predisposing syndrome, Cardiovascular phenotype |
| RS1131691863 |
ANOS1
|
Health Risk |
Pathogenic |
— |
| RS1131691864 |
ATP6V1B2
|
Health Risk |
Likely pathogenic |
— |
| RS1131691865 |
ABCC6
|
Health Risk |
Likely pathogenic |
Arterial calcification, generalized |
| RS1131691866 |
DYRK1A
|
Health Risk |
Likely pathogenic |
DYRK1A-related intellectual disability syndrome, DYRK1A-related intellectual disability syndrome |